Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of Ventilation I: Respiratory Rate01:20

Assessment of Ventilation I: Respiratory Rate

1.4K
Assessment of Ventilation
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
1.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

359
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
359
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

478
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
478
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

406
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
406
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

1.7K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.7K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

220
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
220

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Functional Outcomes After Pediatric Intensive Care Unit Admission for Bronchiolitis: A 12-Month Cohort Study.

Children (Basel, Switzerland)·2026
Same author

Association Between the Introduction of Pediatric Influenza Vaccination and Influenza Diagnoses in Primary Care and Hospitalizations: An Interrupted Time Series Study.

Vaccines·2026
Same author

The Impact of Nirsevimab on the Transport of Critically Ill Children.

Children (Basel, Switzerland)·2026
Same author

Influenza Vaccination in Children During the First Two Seasons of Routine Vaccination Programs (2023-24 and 2024-25) in Central Catalonia, Spain: A Retrospective Study.

International journal of environmental research and public health·2026
Same author

Characterisation of Postural Orthostatic Tachycardia Syndrome (POTS): Findings from a physician chart-audit pre- and post-COVID-19.

Autonomic neuroscience : basic & clinical·2026
Same author

Diagnostic Accuracy of Lung Ultrasound for Pneumonia in Acutely and Critically Ill Neonates, Children, and Young Adults: A Systematic Review and Meta-Analysis.

Diagnostics (Basel, Switzerland)·2025

Related Experiment Video

Updated: Sep 26, 2025

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.6K

RISK score for developing ventilator-associated pneumonia in children: The RISVAP study.

Mònica Girona-Alarcón1,2,3, Sara Bobillo-Perez1,2, Anna Solé-Ribalta1,2,3

  • 1Pediatric Intensive Care Unit, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.

Pediatric Pulmonology
|April 18, 2022
PubMed
Summary

This study developed the RISVAP score to identify children at risk of ventilator-associated pneumonia (VAP). The score helps detect vulnerable pediatric patients for targeted preventative strategies.

Keywords:
healthcare-associated infectionintensive carepediatricsventilator-associated pneumonia

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.0K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K

Related Experiment Videos

Last Updated: Sep 26, 2025

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.6K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.0K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K

Area of Science:

  • Pediatric critical care medicine
  • Infectious disease epidemiology
  • Healthcare-associated infections

Background:

  • Ventilator-associated pneumonia (VAP) is a significant healthcare-associated infection in children, ranking as the second most common.
  • Effective identification of pediatric patients at high risk for VAP is crucial for implementing timely and targeted preventative measures.

Purpose of the Study:

  • To identify independent risk factors associated with the development of VAP in pediatric patients.
  • To develop and validate a novel risk score, the RISVAP score, for predicting VAP in children requiring mechanical ventilation.

Main Methods:

  • A prospective observational study was conducted using data from the multicentre ENVIN-HELICS database (2014-2019).
  • Regression coefficients of identified independent risk factors were used to construct the RISVAP score.
  • The score was validated by assessing its predictive performance using the area under the curve (AUC).

Main Results:

  • A total of 3798 pediatric patients were analyzed, with 97 (2.5%) developing VAP.
  • Key independent risk factors for VAP included female sex, mechanical ventilation (MV) duration > 4 days, pediatric intensive care unit (PICU) length of stay > 7 days, and previous colonization.
  • The developed RISVAP score demonstrated strong predictive accuracy, with an AUC of 0.905.

Conclusions:

  • The RISVAP score represents the first validated tool for assessing VAP risk in pediatric populations.
  • This predictive score can aid clinicians in identifying vulnerable children, enabling the implementation of tailored preventative strategies to reduce VAP incidence.